scorecardresearch
Saturday, May 4, 2024
TopicFDA

Topic: FDA

Modi govt writes to J&J for details on surgical pelvic mesh after US ban

Govt has sought details on the number of the pelvic meshes that Johnson & Johnson has imported into India in the last 3 years.

Sales of pelvic surgical mesh for women could be stopped in India after US ban

The US FDA stopped the sale of the surgical mesh, used to treat the abnormal descent of the pelvis in women, due to a rise in adverse complaints.   

US drug authority warns Indian homoeopathy firm after it finds insects & rodents at factory

Noida-based B.Jain Pharmaceuticals exports homoeopathy medicines to several countries, including US. It also sells products in India for treatment of diabetes, liver ailments.

How India’s culture of ‘jugaad’ is challenging the US drug agency

'Jugaad', translated as creative improvisation, is credited with the rise in technology and drug making in India. But it can have a darker connotation -- get it done at all costs.

Pfizer’s Viagra patent set to end in the US, Indian pharma firms sense huge opportunity

Seven get FDA approval to produce the drug, could send prices crashing in the US by nearly 99%.

This is how GM crop Golden Rice could solve Vitamin-A deficiency in Asia

US food and drug regulator approves Golden Rice for consumption; among Asian nation, Philippines and Bangladesh lead in research and testing of GR2E.

On Camera

Stop targeting Galgotias University students. Focus on politicians instead

Going through their Instagrams and dissecting their ‘statements’ is not the astute political commentary you think it is—it is time for us to back off from targeting 20-year-olds.

High capacity usage, fresh borrowings & new orders — why FY25 could be a big year for pvt investment

Companies are borrowing more from banks and public. Economists say high capacity utilisation & growing new orders could set stage for renewed investment push by India Inc.

China builds road through Shaksgam Valley, India registers protest

New Delhi has, in past, too, objected to Chinese construction activities in Shaksgam Valley. Work in this strategic region gathered pace after the 2017 Doklam stand-off.

Frontrunner is letting the challenger define this poll campaign. Modi still hasn’t found a big theme

A theme has not yet emerged for BJP & people see lack of a contest, which makes it unexciting. For all these reasons, 2024 is turning out to be an unexpectedly theme-less election.